pioneer 9 semaglutide Post hoc analysis of SUSTAIN 6 and 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo PIONEER 6: Oral Semaglutide Passes

Second, the gap between currently available alternatives (semaglutide at 15%) and tirzepatide (20-22%) may close significantly within the next 1-2 years as these newer options reach the market

And now someone suggested tirzepatide might help

Prioritizing protein, vegetables, and whole foods within your reduced-calorie budget ensures you're getting the micronutrients needed to support metabolism and energy levels

It achieves this by improving the body's ability to use insulin, reducing inflammation, and enhancing cholesterol levels

In rare situations, this might increase the risk of cholestasis, especially in people who already have liver or gallbladder conditions